Internal Medicine, Medical Oncology · Plano, TX
NPI
1538102934
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3705 W 15th St
Plano, TX, 75075
Phone (972) 867-3577
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
109,314 services
Medicare patients, 2024
573
Average age 76
Drug cost, 2024
$2.5M
687 prescriptions
Company payments, 2025
$461
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles K Connor was code J1756 (injection, iron sucrose, 1 mg), 19,900 times for 60 patients. In total Charles K Connor billed 109,314 services in 164 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 19,900 | 60 | $0.18 | $3,545 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 9,730 | 23 | $2.35 | $23K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 7,900 | 19 | $44.45 | $351K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 5,810 | 57 | $0.09 | $545 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,700 | 19 | $36.83 | $99K |
| J0897 Injection, denosumab, 1 mg | Office | 2,340 | 22 | $20.40 | $48K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,135 | 63 | $0.09 | $103 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 660 | 25 | $0.25 | $168 |
| 36415 Venipuncture Blood Collection | Office | 660 | 202 | $8.65 | $5,709 |
| 85025 Blood Count | Office | 582 | 192 | $7.60 | $4,423 |
| 80053 Clinical Chemistry | Office | 532 | 188 | $10.35 | $5,506 |
| 99213 Office E&M - Established | Office | 478 | 203 | $62.81 | $30K |
| 96375 Injection Administration | Office | 299 | 80 | $11.45 | $3,425 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 287 | 149 | $11.65 | $3,344 |
| 96413 Chemotherapy Administration | Office | 202 | 91 | $95.62 | $19K |
By year: 2022 $1.1M for 79,794 services; 2023 $1.5M for 119,560 services; 2024 $1.6M for 109,314 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 660 | 202 | $8.65 | $5,709 |
| 85025 Blood Count | 582 | 192 | $7.60 | $4,423 |
| 80053 Clinical Chemistry | 532 | 188 | $10.35 | $5,506 |
| 82728 Clinical Chemistry | 186 | 79 | $13.36 | $2,485 |
| 83540 Clinical Chemistry | 142 | 64 | $6.34 | $900 |
| 83550 Clinical Chemistry | 142 | 64 | $8.57 | $1,217 |
| 83615 Clinical Chemistry | 90 | 42 | $5.87 | $528 |
| 85007 Blood Count | 85 | 28 | $3.72 | $316 |
| 85027 Blood Count | 85 | 28 | $6.34 | $539 |
| 85055 Blood Count | 80 | 29 | $35.03 | $2,802 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles K Connor prescribed most often to Medicare patients was Xarelto (Rivaroxaban), with 51 prescriptions and refills. In total Charles K Connor wrote 687 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xarelto Rivaroxaban | 51 | 83 | Under 11 | $47K |
| Imatinib Mesylate Generic | 48 | 58 | Under 11 | $87K |
| Eliquis Apixaban | 30 | 32 | Under 11 | $19K |
| Hydroxyurea Generic | 28 | 72 | 12 | $914 |
| Warfarin Sodium Generic | 24 | 51 | Under 11 | $68.92 |
| Jakafi Ruxolitinib Phosphate | 24 | 24 | Under 11 | $325K |
| Calquence Acalabrutinib Maleate | 23 | 23 | Under 11 | $340K |
| Exemestane Generic | 21 | 37 | Under 11 | $1,434 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 19 | 19 | 12 | $296 |
| Levothyroxine Sodium Generic | 18 | 20 | Under 11 | $50.74 |
| Acyclovir Generic | 17 | 35 | Under 11 | $186 |
| Dexamethasone Generic | 16 | 16 | Under 11 | $341 |
| Zolpidem Tartrate Generic | 16 | 16 | Under 11 | $142 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 15 | 15 | Under 11 | $683 |
| Letrozole Generic | 14 | 18 | Under 11 | $138 |
Brand drugs: 259 claims; generic drugs: 428 claims; opioid claims: 69.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles K Connor $461 ($461 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $147.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.